XML 32 R20.htm IDEA: XBRL DOCUMENT v3.19.2

SHAREHOLDERS' EQUITY	6 Months Ended
	Jun. 30, 2019
Equity [Abstract]
SHAREHOLDERS' EQUITY	11. SHAREHOLDERS’ EQUITY: Common and Preferred Stock The Company is authorized to issue 200,000,000 shares of $0.01 par value common stock and 5,000,000 shares of $0.01 par value preferred stock. Each share of the Company’s common stock entitles the holder to one vote on all matters to be voted upon by the shareholders. As of June 30, 2019, the Company had issued 48,831,512 shares of common stock, of which 47,465,864 were outstanding and had issued 200,000 shares of preferred stock, all of which were outstanding. During the three months ended June 30, 2019 and 2018, the Company repurchased no shares of common stock. During the six months ended June 30, 2019 and 2018, the Company repurchased 4,011 and 3,774 shares, respectively, of common stock, now held as treasury stock, for an aggregate purchase price of $649,000 and $477,000, respectively. Scientific Advisory Board Awards During the six months ended June 30, 2019 and 2018, the Company granted a total of 1,960 and 2,456 shares, respectively, of fully vested common stock to non-employee members of the Scientific Advisory Board for services performed in 2018 and 2017, respectively. The fair value of shares issued to members of the Scientific Advisory Board was $300,000 for both six-month periods. Dividends During the three months ended June 30, 2019, the Company declared and paid cash dividends of $0.10 per common share, or $4.7 million, and during the six months ended June 30, 2019, the Company declared and paid cash dividends of $0.20 per common share, or $9.4 million, on the Company’s outstanding common stock. On July 30, 2019, the Company’s Board of Directors declared a third quarter dividend of $0.10 per common share to be paid on September 30, 2019 to all shareholders of record as of the close of business on September 16, 2019. All future dividends will be subject to the approval of the Company’s Board of Directors.

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI http://asc.fasb.org/topic&trid=2208762

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938

+ Details

Name:	us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration